Liraglutide Hospital Discharge Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 273 participants.
Also called NCT01919489
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 273 participants
- Sponsor
- Registry
-
NCT01919489
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01919489. Randomized; no masking; primary purpose treatment. Start 2014-03 (actual); primary completion 2020-08-30 (actual). Results posted on 2021-11-03.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Liraglutide Hospital Discharge Trial
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- Liraglutide + OADs
- Intervention (Drug)
- Glargine + OADs
- Lead sponsor
- Emory University
- Collaborator
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct01919489- Content hash
37f3786b98cbd72e61f6dfe5147d247bf982828acdfd2510db6ddffdb584cc52